Delivery Order SPE2DX22D0010-SPE2D825FHF28
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Concerta ER Tabs 27mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $8,217.60 with an ultimate completion date of August 12, 2025, was competitively awarded without set-aside designation. The contract will be performed at AmerisourceBergen's...
- The U.S. Defense Department's Medical Supply Chain awarded a $45,744.59 delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This non-set-aside, competitively awarded contract employs firm fixed pricing and is classified as a delivery order under a larger indefinite delivery contract vehicle. Performance will be executed from...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 30, 2025, for the supply of Concerta ER Tabs 27mg, a medication used to treat attention deficit hyperactivity disorder. This firm fixed price delivery order, valued at $34,825.79, represents a non-set-aside competitive award and is scheduled for completion by July 31, 2025. The contract will be fulfilled from AmerisourceBergen's corporate offices in Conshohocken, Pennsylvania,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order, valued at $67,832.46, represents a competitively awarded, non-set-aside contract with an ultimate completion date of August 28, 2025. AmerisourceBergen Drug Corp, headquartered in...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,738.85 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. The contract, which is classified as a child order under a larger vehicle, carries an ultimate completion date of August 14, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania. This award...
- AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency's Medical Supply Chain on July 30, 2025, valued at $17,035.67 with a firm fixed price structure. The award covers the supply of Concerta ER Tablets 36mg, a controlled-release methylphenidate medication used primarily for attention-deficit/hyperactivity disorder treatment. The delivery order is non-competitive and represents a task order issued under AmerisourceBergen's existing Indefinite Delivery...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Concerta ER Tablets 36mg with a ceiling value of $15,818.06. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle and involves no set-aside designation. The award was made competitively and will be performed at the...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $28,591.14 to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Concerta ER Tablets 36mg. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract requires completion by July 28, 2025, with performance based in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Concerta ER Tabs 36mg with a ceiling value of $62,578.41. This firm fixed-price, non-set-aside contract is scheduled for completion by September 9, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $22,925.61 to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Concerta ER Tabs 36mg, a prescription medication used to treat attention deficit hyperactivity disorder. This firm fixed-price, non-set-aside contract is classified as a delivery order with an ultimate completion date of August 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania....
- SPE2DX22D0010Indefinite Delivery Contract
- SPE2DX22D0010-SPE2D825FHF28Delivery Order
The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Concerta ER Tabs 36mg, a controlled-release methylphenidate medication used to treat attention deficit hyperactivity disorder. This firm fixed-price delivery order has a ceiling value of $9,502.20 and is scheduled for completion by July 29, 2025. The award was made on a competitive basis with no set-aside designation and represents a child contract under AmerisourceBergen's larger pharmaceutical supply arrangement with the government. This delivery order falls under AmerisourceBergen Drug Corp's broader relationship with the Defense Logistics Agency, which includes a significant Indefinite Delivery Contract (IDC) valued at $999,999,999 through December 2026 that enables the company to supply pharmaceutical products and medical commodities to support military healthcare systems globally. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical federal pharmaceutical vendor with extensive experience fulfilling diverse medical procurement requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. The company's federal contract portfolio demonstrates consistent capability in delivering both brand-name and generic medications across multiple therapeutic domains to support defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.5k | 7/28/25 |